Clough Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Clough Capital Partners's LLY Position: Q4 2024 in Review
Clough Capital Partners sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 10,888 shares — an estimated $9.65M sold.
Clough Capital Partners first reported a position in LLY in Q4 2018 and held it in 20 quarters. The position peaked at $25.2M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Clough Capital Partners reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
- Clough Capital Partners sold 10,888 Eli Lilly shares in Q4 2024, an estimated $9.65M.
- Clough Capital Partners first reported a position in Eli Lilly in Q4 2018 and held it in 20 quarters.
- Clough Capital Partners's Eli Lilly position peaked at $25.2M in Q2 2024.
- 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Clough Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.